We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHUY
1751
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$2.23M ﹤0.01%
62,143
+1,969
+3% +$67.3K
PJT icon
1752
PJT Partners
PJT
$4.38B
$2.22M ﹤0.01%
30,750
+775
+3% +$59.5K
RELY icon
1753
Remitly
RELY
$5.14B
$2.22M ﹤0.01%
130,755
+12,134
+10% +$165K
INVA icon
1754
Innoviva
INVA
$1.48B
$2.21M ﹤0.01%
196,731
+10,670
+6% +$129K
BORR
1755
Borr Drilling
BORR
$1.19B
$2.21M ﹤0.01%
291,658
+32,416
+13% +$209K
CIM
1756
Chimera Investment
CIM
$1B
$2.21M ﹤0.01%
130,441
+5,464
+4% +$105K
HZO icon
1757
MarineMax
HZO
$788M
$2.2M ﹤0.01%
76,590
+4,054
+6% +$127K
TVTX icon
1758
Travere Therapeutics
TVTX
$5.78B
$2.2M ﹤0.01%
97,901
+265
+0.3% +$5.63K
EVRI
1759
DELISTED
Everi Holdings
EVRI
$2.2M ﹤0.01%
128,070
+5,687
+5% +$98.3K
USNA icon
1760
Usana Health Sciences
USNA
$286M
$2.2M ﹤0.01%
34,919
+1,837
+6% +$110K
RSP icon
1761
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$2.19M ﹤0.01%
15,119
+250
+2% +$36.6K
ACVA icon
1762
ACV Auctions
ACVA
$1.3B
$2.18M ﹤0.01%
168,771
+9,275
+6% +$101K
MGNI icon
1763
Magnite
MGNI
$3.55B
$2.18M ﹤0.01%
235,262
+6,336
+3% +$67.5K
FLYW icon
1764
Flywire
FLYW
$2.16B
$2.16M ﹤0.01%
73,711
+3,303
+5% +$87K
SYBT icon
1765
Stock Yards Bancorp
SYBT
$2.6B
$2.16M ﹤0.01%
39,223
+1,196
+3% +$69.8K
INFN
1766
DELISTED
Infinera Corporation Common Stock
INFN
$2.16M ﹤0.01%
278,322
+12,436
+5% +$90.4K
QS icon
1767
QuantumScape Corp
QS
$3.74B
$2.16M ﹤0.01%
263,977
+4,199
+2% +$34.1K
CHS
1768
DELISTED
Chicos FAS, Inc.
CHS
$2.16M ﹤0.01%
391,923
+19,071
+5% +$102K
KREF
1769
KKR Real Estate Finance Trust
KREF
$499M
$2.15M ﹤0.01%
189,185
+9,038
+5% +$127K
ENVX icon
1770
Enovix
ENVX
$1.03B
$2.14M ﹤0.01%
163,979
+2,984
+2% +$24.5K
AMRC icon
1771
Ameresco
AMRC
$1.36B
$2.13M ﹤0.01%
43,368
+1,418
+3% +$75.2K
NTB icon
1772
Bank of N.T. Butterfield & Son
NTB
$2.45B
$2.13M ﹤0.01%
78,798
+3,525
+5% +$113K
GDEN
1773
DELISTED
Golden Entertainment
GDEN
$2.12M ﹤0.01%
48,770
+3,873
+9% +$157K
HSII
1774
DELISTED
Heidrick & Struggles
HSII
$2.12M ﹤0.01%
69,813
+3,601
+5% +$110K
EVBG
1775
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.12M ﹤0.01%
61,149
+431
+0.7% +$13.8K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.